ClinConnect ClinConnect Logo
Search / Trial NCT04001595

Global FKRP Registry

Launched by NEWCASTLE UNIVERSITY · Jun 27, 2019

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

Lgmd2 I Lgmdr9 Limb Girdle Muscular Dystrophy Congenital Muscular Dystrophy Muscle Eye Brain Disease Walker Warburg Syndrome Fkrp Gene Mutation

ClinConnect Summary

The Global FKRP Registry is a study aimed at better understanding certain genetic conditions caused by mutations in the FKRP gene. These conditions include Limb Girdle Muscular Dystrophy type R9 (LGMDR9), which is the most common FKRP-related disorder, along with rarer conditions like Congenital Muscular Dystrophy, Muscle-Eye-Brain Disease, and Walker-Warburg Syndrome. By gathering information through questionnaires from patients around the world, the registry hopes to gain valuable insights into these diseases and identify individuals who may be eligible for future clinical trials.

If you or a family member have a confirmed diagnosis of any FKRP-related condition, you may be eligible to participate in this registry, regardless of your age or gender. There are no specific exclusions, so anyone with a genetic confirmation of these conditions can join. Participants can expect to fill out questionnaires that will help researchers learn more about their experiences with the disease. This is an important step in advancing research and potentially leading to new treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients with a confirmed diagnosis of an FKRP-related condition are eligible for inclusion. Diagnosis will be confirmed via genetic testing results.
  • Exclusion Criteria:
  • There is no exclusion criteria for registration with this patient registry.

About Newcastle University

Newcastle University is a leading research institution located in the United Kingdom, renowned for its commitment to advancing healthcare through innovative clinical trials and scientific research. The university's Clinical Trials Unit plays a pivotal role in the design, coordination, and execution of high-quality clinical studies, focusing on a wide range of therapeutic areas. With a multidisciplinary team of experts, Newcastle University fosters collaboration between academia, industry, and healthcare providers, ensuring that research findings translate into meaningful advancements in patient care. Its dedication to excellence and ethical standards positions Newcastle University as a trusted sponsor in the clinical research landscape.

Locations

Newcastle Upon Tyne, , United Kingdom

Newcastle Upon Tyne, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Volker Straub, MD, PhD

Principal Investigator

John Walton Muscular Dystrophy Research Centre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials